This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zuckerman, S. H. Articles by Sandusky, G. Search for Related Content PubMed PubMed Citation Articles by Zuckerman, S. H. Articles by Sandusky, G. Pubmed/NCBI databases Substance via MeSH Related Collections Lipid and lipoprotein metabolism Animal models of human disease Pathophysiology Genetically altered mice

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1476-1483.)
© 1999 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Estrogen-Mediated Increases in LDL Cholesterol and Foam Cell–Containing Lesions in Human ApoB100xCETP Transgenic Mice

Steven H. Zuckerman; Glenn F. Evans; Judi A. Schelm; Patrick I. Eacho; George Sandusky

From the Divisions of Cardiovascular Research (S.H.Z., G.F.E., J.A.S., P.I.E.) and Research Technology & Proteins (G.S.), Lilly Research Labs, DC0434, Indianapolis, Ind 46285.

Correspondence to Steven H. Zuckerman, Division of Cardiovascular Research, Lilly Research Labs, DC0434, Indianapolis, IN 46285. E-mail Zuckerman_Steven{at}Lilly.com

Abstract—The murine double transgenic mouse expressing both human apoB100 and cholesteryl ester transfer protein (CETP), has been used as a model to understand the effects mediated by various therapeutic modalities on serum lipoproteins and on atherosclerotic lesion progression. In the present study the effects of estrogen therapy on serum lipoproteins were investigated after mice were placed on an atherosclerotic diet. The daily oral administration of 20 or 100 µg/kg of 17 -ethinyl estradiol resulted in a significant, dose-dependent increase in LDL cholesterol over a 20-week regimen. These differences were apparent by 6 weeks and further increases were observed through the 20-week period. Although CETP did result in a reduction in total HDL, estrogen did not have any impact on the amount of CETP activity associated with the HDL particles. The significant increase in LDL cholesterol was associated with increases in the amount of apoB100 and B48 and apoE–containing particles. Hepatic apoB message levels, however, were not different between the experimental groups. Although the extent of atherosclerotic lesions was modest, <0.5% of the aortic surface area in the vehicle group, the high-dose estrogen group, showed an increase in lesion area consistent with the elevation in LDL cholesterol. These lesions, primarily restricted to the aortic root and aortic semilunar valves, were more intensely stained with Oil Red O in the high-dose estrogen group when compared with the vehicle controls.

Key Words: estrogen • apoproteins • cholesterol • lipoproteins • transgenic

This article has been cited by other articles:

				M. Westerterp, C. C. van der Hoogt, W. de Haan, E. H. Offerman, G. M. Dallinga-Thie, J. W. Jukema, L. M. Havekes, and P. C.N. Rensen Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in APOE*3-Leiden Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2552 - 2559. [Abstract] [Full Text] [PDF]

				A. C. Casquero, J. A. Berti, A. G. Salerno, E. J. B. Bighetti, P. M. Cazita, D. F. J. Ketelhuth, M. Gidlund, and H. C. F. Oliveira Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice J. Lipid Res., July 1, 2006; 47(7): 1526 - 1534. [Abstract] [Full Text] [PDF]

				P. M. Cazita, J. A. Berti, C. Aoki, M. Gidlund, L. M. Harada, V. S. Nunes, E. C. R. Quintao, and H. C. F. Oliveira Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice J. Lipid Res., January 1, 2003; 44(1): 33 - 40. [Abstract] [Full Text] [PDF]

				J. B. Hodgin and N. Maeda Minireview: Estrogen and Mouse Models of Atherosclerosis Endocrinology, December 1, 2002; 143(12): 4495 - 4501. [Abstract] [Full Text] [PDF]